Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines

被引:7
|
作者
Henson, Brianna [1 ]
Hollingsworth, Hanna [2 ]
Nevois, Erika [3 ]
Herndon, Chris [4 ]
机构
[1] Wake Forest Baptist Hlth Brenner Childrens Hosp, Winston Salem, NC USA
[2] Parkland Hlth & Hosp Syst, Dallas, TX USA
[3] CVS Pharm, Springfield, IL USA
[4] Southern Illinois Univ Edwardsville, Sch Pharm, 200 Univ Pk Dr, Edwardsville, IL 62026 USA
关键词
CGRP; migraine; calcitonin gene-related peptide; erenumab; galcanezumab; fremanezumab; DOUBLE-BLIND; EPISODIC MIGRAINE; RECEPTOR ANTAGONISTS; PREVENTIVE TREATMENT; EFFICACY; SAFETY; ANTIBODY; PHASE-2; TRIAL;
D O I
10.1080/15360288.2019.1690616
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Migraine is highly prevalent and associated with a large socio-economic burden in the United States. Current preventive medications have variable efficacy and their use is often limited by intolerable side effects. Calcitonin gene-related peptide (CGRP) has been identified as an integral part of migraine pathophysiology. There are currently seven CGRP antagonists under investigation, all of which are undergoing or have completed phase 3 clinical trials. Three of the investigated CGRP antagonists are approved for use within and outside of the United States. The trials have resulted in positive efficacy and safety data. The purpose of this review is to evaluate the seven CGRP antagonists and their future place in therapy.
引用
收藏
页码:22 / 31
页数:10
相关论文
共 50 条
  • [1] Calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraines in adults
    Ocheretyaner, Eric R.
    Kofman, Maria
    Quattrocchi, Elaena
    DRUGS IN CONTEXT, 2022, 11
  • [2] Preparation of imidazoles as potent calcitonin gene-related peptide (CGRP) antagonists
    Tora, George
    Degnan, Andrew P.
    Conway, Charles M.
    Kostich, Walter A.
    Davis, Carl D.
    Pin, Sokhom S.
    Schartman, Richard
    Xu, Cen
    Widmann, Kimberly A.
    Macor, John E.
    Dubowchik, Gene M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (20) : 5684 - 5688
  • [3] Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine
    Durham, Paul L.
    Vause, Carrie V.
    CNS DRUGS, 2010, 24 (07) : 539 - 548
  • [4] Discovery of imidazoles as potent calcitonin gene-related peptide (CGRP) antagonists
    Tora, George
    Degnan, Andrew P.
    Chen, Ling
    Conway, Charles M.
    Luo, Guanglin
    Xu, Cen
    Macor, John E.
    Dubowchik, Gene M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [5] Calcitonin gene-related peptide (CGRP) antagonists and migraine - Is this a new era?
    Goadsby, Peter J.
    NEUROLOGY, 2008, 70 (16) : 1300 - 1301
  • [6] Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine
    Durham P.L.
    Vause C.V.
    CNS Drugs, 2010, 24 (7) : 539 - 548
  • [7] Pan-Colitis Secondary to Calcitonin Gene-Related Peptide (CGRP) Antagonist for Migraines
    Ahsan, Mohammed
    Provance, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1770 - S1770
  • [8] Peptide Antagonists of the Calcitonin Gene-Related Peptide (CGRP) Receptor With Improved Pharmacokinetics and Pharmacodynamics
    Miranda, Les P.
    Shi, Licheng
    Holder, Jerry R.
    Wright, Marie
    Gegg, Colin V.
    Johnson, Eileen
    Wild, Kenneth
    Stenkilsson, Michael
    Doellgast, George
    Manning, Barton H.
    Salyers, Kevin
    BIOPOLYMERS, 2013, 100 (04) : 422 - 430
  • [9] Non-peptide calcitonin gene-related peptide (CGRP) receptor antagonists.
    Daines, RA
    Sham, KKC
    Taggart, JJ
    Kingsbury, WD
    Chan, J
    Breen, A
    Disa, J
    Aiyar, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 237 - MEDI
  • [10] Calcitonin gene-related peptide (CGRP) in migraine
    Olesen, Jes
    CEPHALALGIA, 2011, 31 (04) : 510 - 510